Metabolic & Cardiometabolic
Part of Biotech - Drug Development
 LLY | Eli Lilly & Co. | $1.0t | $1280.90 | +0.7% | 1.6M |
 AZN | AstraZeneca PLC | $243.3b | $170.88 | +0.8% | 2.3M |
 MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $11.5b | $437.92 | +0.8% | 204.0K |
 PTGX | Protagonist Therapeutics, Inc | $9.1b | $141.14 | +1.3% | 323.2K |
 TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.1b | $52.97 | +0.0% | 2.3M |
 KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $5.9b | $73.47 | -4.9% | 1.3M |
 TVTX | Travere Therapeutics, Inc. Common Stock | $5.4b | $49.87 | -0.2% | 1.9M |
 VKTX | Viking Therapeutics, Inc | $3.8b | $24.20 | -0.7% | 3.2M |
 MBX | MBX Biosciences, Inc. Common Stock | $2.8b | $50.24 | +3.7% | 586.0K |
 NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $2.8b | $19.54 | -0.9% | 1.5M |
 MLYS | Mineralys Therapeutics, Inc. Common Stock | $2.1b | $20.92 | +0.0% | 607.0K |
 SEPN | Septerna, Inc. Common Stock | $1.8b | $41.44 | +2.4% | 239.1K |
 KLRA | Kailera Therapeutics, Inc. Common Stock | $1.7b | $12.52 | -0.7% | 452.0K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $31.10 | +0.3% | 311.7K |
 KARD | Kardigan, Inc. Common Stock | $1.4b | $12.62 | -1.4% | 183.8K |
 MNKD | Mannkind Corporation | $1.2b | $3.18 | +1.3% | 1.7M |
 ESPR | Esperion Therapeutics, Inc. | $0.8b | $3.19 | 0.0% | N/A |
 LXRX | Lexicon Pharmaceuticals, Inc. | $0.8b | $1.46 | +1.8% | 2.0M |
 GYRE | Gyre Therapeutics, Inc. Common Stock | $0.8b | $6.08 | +3.8% | 81.3K |
 SGMT | Sagimet Biosciences Inc. Series A Common Stock | $0.6b | $9.82 | -0.2% | 579.3K |
 ALT | Altimmune, Inc. Common Stock | $0.5b | $2.05 | -3.5% | 3.2M |
 RZLT | Rezolute, Inc. Common Stock (NV) | $387.9m | $3.81 | -1.2% | 1.4M |
 BIOA | BioAge Labs, Inc. Common Stock | $303.4m | $5.11 | -2.4% | 467.2K |
 ORMP | Oramed Pharmaceuticals Inc. | $186.8m | $4.22 | -1.7% | 91.9K |
 CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $171.3m | $1.13 | 0.0% | 574.8K |
 VTVT | vTv Therapeutics Inc. Class A Common Stock | $120.9m | $25.96 | +2.2% | 14.7K |
 VANI | Vivani Medical, Inc. Common Stock (DE) | $111.0m | $1.13 | +0.9% | 98.9K |
 AARD | Aardvark Therapeutics, Inc. Common Stock | $109.2m | $1.08 | -21.6% | 4.9M |
 MIST | Milestone Pharmaceuticals Inc. Common Shares | $100.8m | $0.65 | -0.7% | 795.8K |
 BMEA | Biomea Fusion, Inc. Common Stock | $92.1m | $0.63 | +5.3% | 1.5M |
 TENX | Tenax Therapeutics, Inc. | $74.1m | $1.66 | -4.1% | 1.1M |
 GUTS | Fractyl Health, Inc. Common Stock | $64.7m | $1.07 | -1.4% | 349.2K |
 VERU | Veru Inc. | $42.8m | $2.21 | -1.3% | 80.5K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $34.6m | $4.70 | -2.3% | 32.6K |
 GRDX | GridAI Technologies Corp. Common Stock | $27.2m | $5.58 | -0.1% | 55.9K |
 LPCN | Lipocine Inc. | $16.9m | $1.43 | -1.4% | 90.5K |
 NCEL | NewcelX Ltd. Ordinary Shares | $16.5m | $2.63 | -11.1% | 16.2K |
 MTVA | MetaVia Inc. Common Stock | $10.1m | $1.29 | -9.4% | 135.4K |
 SKYE | Skye Bioscience, Inc. Common Stock | $7.4m | $1.57 | 0.0% | 15.8K |
 CURX | Curanex Pharmaceuticals Inc Common Stock | $7.4m | $4.92 | 0.0% | 13.5K |
 GLMD | Galmed Pharmaceuticals Ltd. | $4.3m | $4.59 | 0.0% | N/A |
 CVKD | Cadrenal Therapeutics, Inc. Common Stock | $3.4m | $0.91 | -4.2% | 49.2K |
 ELAB | PMGC Holdings Inc. Common Stock | $2.7m | $2.73 | -1.7% | 16.8K |
 TCRT | Alaunos Therapeutics, Inc. Common Stock | $2.1m | $2.08 | -7.9% | 509.0K |